Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Histone methyltransferase that specifically monomethylates 'Lys-4' of histone H3. Zusätzlich bieten wir Ihnen SETD7 Antikörper (113) und SETD7 Kits (6) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 12 products:
Methylation at K436 and K595 respectively by Set7 increases the stability and DNA binding ability of Gli3 (zeige GLI3 Proteine), resulting in an enhancement of Shh (zeige SHH Proteine) signaling activation.
the methyltransferase Set9 potentiates TGF-beta (zeige TGFB1 Proteine) signaling by targeting Smad7 (zeige SMAD7 Proteine), an inhibitory downstream effector.
SETD7 plays a critical role in HCC (zeige FAM126A Proteine), and its immunohistochemistry signature provides potential clinical significance for personalized prediction of HCC (zeige FAM126A Proteine) prognosis.
These findings underscore the role of KMT7 as an important monomethyltransferase regulating HIV transcription through Tat (zeige TAT Proteine).
High SET7 expression is associated with breast cancer.
SET7 was required for GATA1 (zeige GATA1 Proteine)-induced breast tumor angiogenesis and growth in nude mice. GATA1 (zeige GATA1 Proteine) and SET7 are independent poor prognostic factors in breast cancer.
SET7/SET9-mediated YY1 (zeige YY1 Proteine) methylation was shown to be involved in YY1 (zeige YY1 Proteine)-regulated gene transcription and cell proliferation.
These results demonstrate that S...O chalcogen bonds contribute to AdoMet (zeige MAT1A Proteine) recognition and can enable methyltransferases to distinguish between substrate and product.
Reduced expression of SET7 is associated with gastric cancer progression.
study identified a novel locus associated with serum lycopene concentrations and results raise a number of possibilities regarding the nature of the relationship between SETD7 and lycopene, both independently associated with prostate cancer.
SETD7 plays an important role in intestinal epithelial cell (IEC) biology during infection.
We observe Set7-mediated modification of serum response factor (SRF) and mono-methylation of histone H4 lysine 4 (H3K4me1) regulate gene expression. We conclude the broad substrate specificity of Set7 serves to control key transcriptional networks in embryonic stem cells.
SETD7 is required for Wnt (zeige WNT2 Proteine)-driven intestinal tumorigenesis and regeneration. SETD7-dependent methylation of YAP (zeige YAP1 Proteine) facilitates Wnt (zeige WNT2 Proteine)-induced nuclear accumulation of beta-catenin (zeige CTNNB1 Proteine).
SET7/9 regulates Nos2 expression through methylation of H3K4 in beta cells.
Data indicate that the ability of transcription factor Pdx1 (zeige PDX1 Proteine) to regulate genes in beta cells is partially dependent upon its methylation by methyltransferase Set7/9.
study found that Set7 is a modifier of the Hippo pathway. Mice that lack Set7 have a larger progenitor compartment in the intestine, coinciding with increased expression of Yes-associated protein target genes.
The response to hyperglycemia in vascular endothelial cells involves Set7 mediated changes in chromatin remodeling and gene expression.
Set7/9-mediated methylation of p53 (zeige TP53 Proteine) does not represent a major regulatory event and does not appreciably control p53 (zeige TP53 Proteine) activity in vivo.
Set7/9 is dispensable for p53 (zeige TP53 Proteine) function in the mouse.
Histone methyltransferase that specifically monomethylates 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. Plays a central role in the transcriptional activation of genes such as collagenase or insulin. Recruited by IPF1/PDX-1 to the insulin promoter, leading to activate transcription. Has also methyltransferase activity toward non-histone proteins such as p53/TP53, TAF10, and possibly TAF7 by recognizing and binding the -K in substrate proteins. Monomethylates 'Lys-189' of TAF10, leading to increase the affinity of TAF10 for RNA polymerase II. Monomethylates 'Lys-372' of p53/TP53, stabilizing p53/TP53 and increasing p53/TP53-mediated transcriptional activation.
, SET domain-containing protein 7
, histone H3-K4 methyltransferase SETD7
, histone H3-lysine 4-specific methyltransferase
, histone-lysine N-methyltransferase SETD7
, lysine N-methyltransferase 7
, H3-K4 methyltransferase